Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Onconova Therapeutics, Inc. (ONTX)  
$0.73 0.00 (0.00%) as of 4:30 Thu 5/20


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 179,650,000
Market Cap: 131.14(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.73 - $0.73
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Onconova Therapeutics is a biopharmaceutical company focused on discovering and developing small molecule product candidates primarily to treat cancer. Co. has three clinical-stage product candidates and preclinical programs. Substantially all of Co.'s effort is focused on its primary product candidate, rigosertib, which has been tested in an intravenous formulation as a single agent for patients with higher-risk myelodysplastic syndromes (MDS), and an oral formulation as a single agent in lower risk MDS or in combination with azacitidine for patients with higher-risk MDS. Co.'s other product candidate, Briciclib, is a small molecule targeting an intracellular regulatory protein, Cyclin D1.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-29 2023-11-28 2023-05-30 2022-05-30

   
Records found: 124
  Page 2 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Guerin Mark Patrick CFO AND COO   •       –      –    2023-06-12 4 OE $0.00 $0 D/D 5,500 23,691     -
   Guerin Mark Patrick CFO AND COO   •       –      –    2023-02-07 4 D $1.36 $2,428 D/D (1,785) 18,191     -
   Guerin Mark Patrick CFO AND COO   •       –      –    2023-02-07 4 OE $0.00 $0 D/D 6,900 19,976     -
   Gelder Mark S. Md CHIEF MEDICAL OFFICER   •       –      –    2023-02-07 4 D $1.36 $1,689 D/D (1,242) 10,487     -
   Gelder Mark S. Md CHIEF MEDICAL OFFICER   •       –      –    2023-02-07 4 OE $0.00 $0 D/D 5,833 11,729     -
   Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF   •       •      –    2023-02-07 4 D $1.36 $9,489 D/D (6,977) 40,477     -
   Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF   •       •      –    2023-02-07 4 OE $0.00 $0 D/D 21,320 47,454     -
   Guerin Mark Patrick CFO AND COO   •       –      –    2022-08-03 4 D $1.32 $1,789 D/D (1,355) 13,076     -
   Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF   •       •      –    2022-08-03 4 D $1.32 $6,022 D/D (4,562) 26,134     -
   Gelder Mark S. Md CHIEF MEDICAL OFFICER   •       –      –    2022-08-03 4 D $1.32 $1,498 D/D (1,135) 5,896     -
   Guerin Mark Patrick CFO AND COO   •       –      –    2022-08-02 4 OE $0.00 $0 D/D 4,750 14,431     -
   Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF   •       •      –    2022-08-02 4 OE $0.00 $0 D/D 12,566 30,696     -
   Gelder Mark S. Md CHIEF MEDICAL OFFICER   •       –      –    2022-08-02 4 OE $0.00 $0 D/D 4,650 7,031     -
   Oler Abraham N. SVP Corp Dev & Gen Counsel   •       –      –    2022-01-28 4 AB $1.67 $2,505 D/D 1,500 24,514     -
   Oler Abraham N. SVP Corp Dev & Gen Counsel   •       –      –    2022-01-21 4 AB $2.02 $3,030 D/D 1,500 23,014     -
   Oler Abraham N. SVP CORP DEV & GEN COUNSEL   •       –      –    2022-01-14 4 AB $2.20 $3,300 D/D 1,500 21,514     -
   Oler Abraham N. SVP Corp Dev & Gen Counsel   •       –      –    2022-01-07 4 AB $2.39 $3,585 D/D 1,500 20,014     -
   Oler Abraham N. SVP Corp Dev & Gen Counsel   •       –      –    2021-11-18 4 OE $3.00 $15,000 D/D 5,000 17,514     -
   Oler Abraham N. SVP Corp Dev & Gen Counsel   •       –      –    2021-09-28 4 B $4.20 $10,000 D/D 2,381 12,515 2.74 -100%     
   Gelder Mark S. Md Chief Medical Officer   •       –      –    2021-09-28 4 B $4.20 $10,000 D/D 2,381 2,381 2.74 -100%     
   Marino James J Director   –       •      –    2021-09-28 4 B $4.20 $24,998 D/D 5,952 21,334 2.39 -100%     
   Fruchtman Steven M President, Chief Executive Off   •       •      –    2021-09-28 4 B $4.20 $10,000 D/D 2,381 18,130 2.81 -100%     
   Marino James J Director   –       •      –    2021-02-16 4 B $1.00 $25,000 D/D 25,000 230,716 2.39 -40%     
   Shoemaker Mary Teresa Director   –       •      –    2021-02-16 4 B $1.00 $13,000 D/D 13,000 50,735 2.39 -40%     
   Oler Abraham N. SVP Corp Dev & Gen Counsel   •       –      –    2021-02-16 4 B $1.00 $12,000 D/D 12,000 152,000 2.74 -40%     
  124 Records found
  1  2  3  4  5   
  Page 2 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us